Durvalumab May Improve Survival of Non-small Cell Lung Cancer Patients

Non-small cell lung cancer patients have improved survival rate with durvalumab along with platinum-based chemoradiotherapy.

from Medindia Health News https://ift.tt/2NK7Csa